ANDVX | DOXGX | ANDVX / DOXGX | |
Total Expense Ratio | 0.65 | 0.41 | 159% |
Annual Report Gross Expense Ratio | 0.65 | 0.46 | 141% |
Fund Existence | 12 years | 3 years | - |
Gain YTD | 2.071 | 6.911 | 30% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500000 | 2500 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 506M | 117B | 0% |
Annual Yield % from dividends | 1.96 | 1.47 | 133% |
Returns for 1 year | 5.58 | 7.74 | 72% |
Returns for 3 years | -2.80 | 30.52 | -9% |
Returns for 5 years | 22.01 | N/A | - |
Returns for 10 years | -25.04 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 8.79 | 0.23 | +2.67% |
Global X Genomics & Biotechnology ETF | |||
PFF | 31.00 | 0.09 | +0.29% |
iShares Preferred&Income Securities ETF | |||
FLC | 17.05 | 0.04 | +0.22% |
Flaherty & Crumrine Total Return Fund | |||
KSEA | 27.00 | N/A | N/A |
KraneShares Rockefeller Ocean Engagement ETF | |||
EUSB | 43.12 | -0.04 | -0.09% |
iShares ESG Advanced Ttl USD Bd Mrkt ETF |